RxDoctor Payments Data

Shahan Yacoubian, MD

Adult Reconstructive Orthopaedic Surgery · Burbank, CANPI 1558331041

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $171,042 of the $213,650 with a category attached, or 80.1%. Encore Medical, LP accounts for 95.5% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $48,537 and has fallen 62.9% since, to $18,017 in 2025.

$213,650in general payments, 2019–2025

Across 205 payments — averaging $1042.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$204K
  • Think Surgical, Inc.$8K
  • Insight Medical Systems, Inc.$288
  • Stryker$236
  • Amgen$229
  • US Implant Solutions, LLC$174
  • plus $726 from 14 others
$9,009in research payments, 2019–2025

Across 8 payments — averaging $1126.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Encore Medical, LP$9K

What the payments were for

  • Royalty or licence$26,38312%
  • Consulting fees$171,04280%
  • Travel & lodging$12,6236%
  • Food & beverage$3,6032%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$213,650 in reported general payments places this provider in the 85th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$1,201,080
Medicare patients
1,266
Services billed
11,824

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib26$678
Cephalexin82$234
Methylprednisolone37$224
Alendronate Sodium50$137
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$125
Ibuprofen24$98
Tramadol Hcl20$83
Meloxicam34$72
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$69
Clindamycin Hcl11$44
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$38

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Burbank

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →